Howard Horn, Chief Financial Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 15,884 shares at $31.51 ($501K) on 2025-10-13, disclosed to the SEC on 2025-10-14.
Open-market sale of $501k RARE by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.51 | 7,942 | $250K | 50.0% |
| 2 | $31.51 | 7,942 | $250K | 50.0% |
| Total | $31.51 avg | 15,884 | $501K | 100% |
| Filing → |
| RARE | SELL | 2026-06-01 | $111K | — | Filing → |
| RARE | SELL | 2026-05-04 | $117K | — | Filing → |
| RARE | SELL | 2026-04-02 | $98K | — | Filing → |